摘要:
To provide a pharmaceutical agent or an antitumor agent useful for the treatment and/or prevention of gastrointestinal cancer, leukemia, pituitary tumor, small cell lung cancer, thyroid cancer, and neuroastrocytoma. The antitumor agent containing, as an active ingredient, a 1,5-benzodiazepine derivative represented by the following formula (1): (wherein R1 represents a C1-6 alkyl group; R2 represents a phenyl group or a cyclohexyl group; and Y represents a single bond or a C1-4 alkylene group) or a pharmaceutically acceptable salt thereof.
摘要:
First power load apparatuses that use power from a power storage apparatus when a total power consumption amount of all of the plurality of power load apparatuses is greater than or equal to a threshold, and second power load apparatuses not included among the first power load apparatuses are included. A power gateway apparatus stops the supply of power from a power supply system to the first power load apparatuses and performs power supply from the power storage apparatus to the first power load apparatuses when a sum of a total power consumption amount of the second power load apparatuses and a total power consumption amount of the first power load apparatuses exceeds a threshold indicating a maximum value of the system power consumption amount. The power gateway apparatus supplies power from the power generation apparatus to the first power load apparatuses with priority to power from the power network.
摘要:
First power load apparatuses that use power from a power storage apparatus when a total power consumption amount of all of the plurality of power load apparatuses is greater than or equal to a threshold, and second power load apparatuses not included among the first power load apparatuses are included. A power gateway apparatus stops the supply of power from a power supply system to the first power load apparatuses and performs power supply from the power storage apparatus to the first power load apparatuses when a sum of a total power consumption amount of the second power load apparatuses and a total power consumption amount of the first power load apparatuses exceeds a threshold indicating a maximum value of the system power consumption amount. The power gateway apparatus supplies power from the power generation apparatus to the first power load apparatuses with priority to power from the power network.
摘要:
To provide a pharmaceutical agent or an antitumor agent useful for the treatment and/or prevention of gastrointestinal cancer, leukemia, pituitary tumor, small cell lung cancer, thyroid cancer, and neuroastrocytoma. The antitumor agent containing, as an active ingredient, a 1,5-benzodiazepine derivative represented by the following formula (1): (wherein R1 represents a C1-6 alkyl group; R2 represents a phenyl group or a cyclohexyl group; and Y represents a single bond or a C1-4 alkylene group) or a pharmaceutically acceptable salt thereof.
摘要:
To provide a pharmaceutical agent or an antitumor agent useful for the treatment and/or prevention of gastrointestinal cancer, leukemia, pituitary tumor, small cell lung cancer, thyroid cancer, and neuroastrocytoma. The antitumor agent containing, as an active ingredient, a 1,5-benzodiazepine derivative represented by the following formula (1): (wherein R1 represents a C1-6 alkyl group; R2 represents a phenyl group or a cyclohexyl group; and Y represents a single bond or a C1-4 alkylene group) or a pharmaceutically acceptable salt thereof.
摘要:
To provide a cancer pain therapeutic and/or prophylactic agent which can be administered to a patient for a long period of time from the early stage to the final stage of the cancer pain therapy, instead of conventional non-opioid analgesic agents or opioid analgesic agents.The cancer pain therapeutic and/or prophylactic agent containing, as an active ingredient, a 1,5-benzodiazepine derivative represented by formula (1):(wherein R1 represents a C1-6 alkyl group, R2 represents a phenyl group or a cyclohexyl group, and Y represents a single bond or a C1-4 an alkylene group) or a pharmaceutically acceptable salt thereof.